Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China · Delayed Price · Currency is CNY 2.890
-0.030 (-1.03%)
At close: Feb 13, 2026
SHE:002622 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -77.6 | -37.69 | -94.37 | -256.79 | -75.98 | -297.12 |
Depreciation & Amortization | 64.32 | 64.32 | 63.66 | 63.35 | 16.06 | 12.32 |
Other Amortization | 14.78 | 14.78 | 13.75 | 10.87 | 1.59 | 0.47 |
Loss (Gain) From Sale of Assets | 0.58 | 0.58 | -4.22 | -0.87 | -0.03 | - |
Asset Writedown & Restructuring Costs | 0.21 | 0.21 | 0.1 | 21.29 | 14.64 | 156.3 |
Loss (Gain) From Sale of Investments | 3.7 | 3.7 | 73.61 | -76.98 | 17.43 | -66.52 |
Provision & Write-off of Bad Debts | 3.36 | 3.36 | 2.51 | 2.84 | 0.63 | 4.02 |
Other Operating Activities | 49.82 | 63.12 | 82.52 | 38.46 | 42.87 | 148.9 |
Change in Accounts Receivable | -28.09 | -28.09 | 45.65 | -21.72 | 36.71 | -94.12 |
Change in Inventory | 11.39 | 11.39 | -8.31 | -2.17 | -3.98 | -0.08 |
Change in Accounts Payable | 5.12 | 5.12 | -35.02 | 260.07 | -32.46 | 133.88 |
Change in Other Net Operating Assets | -10.28 | -10.28 | -3.1 | 2.97 | 0.64 | 2.13 |
Operating Cash Flow | 39.15 | 92.36 | 137.02 | 32.25 | 18.37 | 65.34 |
Operating Cash Flow Growth | -70.85% | -32.59% | 324.94% | 75.56% | -71.89% | 187.22% |
Capital Expenditures | -11.51 | -13.79 | -33.63 | -23.99 | -5.74 | -0.59 |
Sale of Property, Plant & Equipment | -0.01 | 0.01 | 0.68 | 0.21 | 0.05 | 8.4 |
Cash Acquisitions | - | - | - | -20.69 | -34.37 | - |
Divestitures | - | - | 17.6 | 11.89 | - | 74.74 |
Investment in Securities | - | - | - | 74 | 94 | 30.06 |
Other Investing Activities | 0.71 | 0.71 | 3.39 | - | - | 5 |
Investing Cash Flow | -10.8 | -13.06 | -11.95 | 41.42 | 53.94 | 117.61 |
Long-Term Debt Issued | - | 78.4 | 17 | 90.5 | - | 267.08 |
Long-Term Debt Repaid | - | -142.01 | -93.02 | -213.23 | -40.58 | -274.55 |
Net Debt Issued (Repaid) | -54.81 | -63.61 | -76.02 | -122.73 | -40.58 | -7.47 |
Common Dividends Paid | -23.54 | -25.53 | -25.37 | -22.64 | -34.63 | -55.36 |
Other Financing Activities | -0.42 | -0.5 | - | 1.26 | 0.1 | - |
Financing Cash Flow | -70.45 | -89.64 | -101.39 | -144.1 | -75.11 | -62.83 |
Foreign Exchange Rate Adjustments | 0 | 0 | -0 | - | - | - |
Net Cash Flow | -42.1 | -10.35 | 23.69 | -70.43 | -2.8 | 120.13 |
Free Cash Flow | 27.65 | 78.57 | 103.4 | 8.26 | 12.63 | 64.75 |
Free Cash Flow Growth | -73.22% | -24.01% | 1152.17% | -34.62% | -80.49% | 186.89% |
Free Cash Flow Margin | 3.67% | 9.12% | 13.66% | 1.65% | 7.51% | 56.63% |
Free Cash Flow Per Share | 0.03 | 0.09 | 0.12 | 0.01 | 0.01 | 0.08 |
Cash Income Tax Paid | 6.18 | 8.86 | 2.95 | 9.93 | 5.16 | 8 |
Levered Free Cash Flow | 60.83 | 85.66 | 102.25 | 293.55 | 83.58 | 196.02 |
Unlevered Free Cash Flow | 86.41 | 112.46 | 130.14 | 332.67 | 107.84 | 221.15 |
Change in Working Capital | -20.02 | -20.02 | -0.55 | 230.08 | 1.15 | 35.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.